Lv6
2542 积分 2024-12-10 加入
Oral Small-Molecule GLP-1 Receptor Agonists: Lessons from Clinical Candidates and a Blueprint for Next-Generation Design
8天前
已完结
Discovery and Characterization of a Cereblon-Based Degrader for PTP1B and TCPTP
8天前
已完结
Causes and consequences of discontinuation of GLP1RAs or tirzepatide
1个月前
已完结
Discovery of Novel Alkynylbenzene Scaffold-Based PTPN2-Selective Degrader PD-305 with Exceptional Potency and In Vivo Efficacy
1个月前
已完结
Novel Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) Inhibitors for Cancer Treatment
1个月前
已完结
Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors
1个月前
已完结
Synthesis and Structure-Activity Optimization of Azepane-Containing Derivatives as PTPN2/PTPN1 Inhibitors
1个月前
已完结
Development of Novel PTPN2/1 Inhibitors for the Treatment of Melanoma
1个月前
已完结
Targeting Protein Tyrosine Phosphatase Nonreceptor Type 2 with a Novel Inhibitor for the Treatment of Melanoma
1个月前
已完结
Abstract 4505: Discovery of a cebrelon-based PTPN1/PTPN2 dual targeting degrader for cancer immunotherapy
1个月前
已关闭
皖公网安备34019202002308
